Rani Therapeutics Holdings (RANI) Other financing activities (2021 - 2025)

Rani Therapeutics Holdings' Other financing activities history runs 5 years deep, the most recent figure standing at $12000.0 for Q4 2025.

• On a quarterly basis, Other financing activities rose 125.0% year-over-year to $12000.0 in Q4 2025; TTM through Mar 2026 was $12000.0, a 99.86% decrease from a year earlier, with the FY2025 full-year figure at $12000.0, down 76.47% from the prior year.
• Other financing activities advanced to $12000.0 in Q4 2025 per RANI's latest filing, from -$3.9 million in the prior quarter.
• Across five years, Other financing activities topped out at $8.9 million in Q3 2024 and bottomed at -$3.9 million in Q3 2025.
• The 5-year median for Other financing activities is $13000.0 (2021), against an average of $595533.3.
• Across the five-year window, Other financing activities plunged 369.39% in 2023 and soared 3353.72% in 2025, its largest moves.
• Year by year, Other financing activities stood at -$13000.0 in 2021, then tumbled by 1038.46% to -$148000.0 in 2022, then jumped by 127.03% to $40000.0 in 2023, then sank by 220.0% to -$48000.0 in 2024, then jumped by 125.0% to $12000.0 in 2025.
• Per Business Quant, the three latest RANI Other financing activities figures stand at $12000.0 (Q4 2025), -$3.9 million (Q3 2025), and $3.9 million (Q2 2025).